VIDEO: Mitro discusses potential avenues for new drug therapies

Issue: September 25, 2021

ByTom Mitro

Add topic to email alerts

Please provide your email address to receive an email when new articles are posted on Ophthalmic Business.

Subscribe

Added to email alerts

You've successfully added Ophthalmic Business to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added Ophthalmic Business to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

LAS VEGAS — At the Eyecelerator@ASCRS meeting, Tom Mitro, president and chief operating officer at Aerie, discusses candidates that may help Aerie gain a foothold in other ophthalmic disease states, including a pan-VEGF inhibitor.

Published by:

Sources/Disclosures

Collapse

Source:

Tom Mitro

Read more from American Society of Cataract and Refractive Surgery Meeting

View all

April 30, 2025

2 min watch

Save

VIDEO: Miebo improves total corneal fluorescein staining starting at 2 weeks

April 29, 2025

3 min read

Save

‘Cincinnati Procedure’: First-line treatment for limbal stem cell deficiency

April 29, 2025

1 min watch

Save

VIDEO: Phentolamine improves symptoms as soon as 1 hour after dilation

April 28, 2025

2 min watch

Save

VIDEO: Toric IOL implantation yields ‘wonderful results’ in low astigmatism

April 28, 2025

2 min read

Save

Patients satisfied with dropless cataract regimen

April 27, 2025

1 min read

Save

Presbyopia-correcting IOL demonstrates good visual acuity in light, dark settings

April 27, 2025

2 min read

Save

JP Morgan banker says innovation will drive ophthalmology through current market cycle

April 27, 2025

1 min read

Save

Good visual, refractive results seen with Tecnis Eyhance in previously treated myopic eyes

April 26, 2025

1 min read

Save

Hydrodissection remains relevant in cataract surgery

Previous

Next

Read more about

drug therapies

ophthalmic business

Add topic to email alerts

Please provide your email address to receive an email when new articles are posted on Ophthalmic Business.

Subscribe

Added to email alerts

You've successfully added Ophthalmic Business to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added Ophthalmic Business to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment